Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010-2050) estimated using the 2010 Census. Neurology 2013;80(19):1778–83.
Dilworth-Anderson P, Hendrie HC, Manly JJ, Khachaturian AS, Fazio S. Diagnosis and assessment of Alzheimer’s disease in diverse populations. Alzheimers Dement 2008;4(4):305–9.
Manly J, Mayeux R. Ethnic differences in dementia and Alzheimer’s disease. In: Anderson N, Bulatao R, Cohen B, eds. li Critical perspectives on racial and ethnic differentials in health in late life. Washington, D.C.: National Academies Press; 2004:p. 95–141.
Anstey KJ, von Sanden C, Salim A, O’Kearney R. Smoking as a risk factor for dementia and cognitive decline: A meta-analysis of prospective studies. Am J Epidemiol 2007;166(4):367–78.
Rusanen M, Kivipelto M, Quesenberry CP, Zhou J, Whitmer RA. Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med 2010;171(4):333–9.
Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: Asystematic review and meta-analysis. Lancet Neurol 2009;8(11):1006–18.
Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology 2008;71:1057–64.
Raji CA, Ho AJ, Parikshak NN, Becker JT, Lopez OL, Kuller LH, et al. Brain structure and obesity. Hum Brain Mapp2010;31(3):353–64.
Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kåreholt I, Winblad B, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005;62:1556–60.
Xu WL, Atti AR, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Midlife overweight and obesity increase late-life dementia risk: A population-based twin study. Neurology 2011; 3;76(18):1568–74.
Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O’Meara ES, Longstreth WT, et al. Midlife and late-life obesity and the risk of dementia: Cardiovascular Health Study. Arch Neurol 2009;66(3):336–42.
Rönnemaa E, Zethelius B, Lannfelt L, Kilander L. Vascular risk factors and dementia: 40-year follow-up of a population-based cohort. Dement Geriatr Cogn Disord 2011;31(6):460–6.
Luchsinger JA, Cheng D, Tang MX, Schupf N, Mayeux R. Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis Assoc Disord 2012;26(2):101–5.
Wu W, Brickman AM, Luchsinger J, Ferrazzano P, Pichiule P, Yoshita M, et al. The brain in the age of old: The hippocampal formation is targeted differentially by diseases of late life. Ann Neurol 2008;64:698–706.
Ohara T, Doi Y, Ninomiya T, Hirakawa Y, Hata J, Iwaki T, et al. Glucose tolerance status and risk of dementia in the community: The Hisayama Study. Neurol 2011;77:1126–34.
Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol 2011;7(3):137–52.
Ahtiluoto S, Polvikoski T, Peltonen M, Solomon A, Tuomilehto J, Winblad B, et al. Diabetes, Alzheimer disease, and vascular dementia: A population-based neuropathologic study. Neurology 2010;75(13):1195–202.
Cheng D, Noble J, Tang MX, Schupf N, Mayeux R, Luchsinger JA. Type 2 diabetes and late-onset Alzheimer’s disease. Dement Geriatr Cogn Disord 2011;31(6):424–30.
Solomon A, Kivipelto M, Wolozin B, Zhou, J, Whitmer, RA. Midlife serum cholesterol and increased risk of Alzheimer’s and vascular dementia three decades later. Dement and Geriatr Disord 2009;28:75–80.
Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, et al. Midlife blood pressure and dementia: The Honolulu-Asia Aging Study. Neurobiol Aging 2000;21(1):49–55.
Ninomiya T, Ohara T, Hirakawa Y, Yoshida D, Doi Y, Hata J, et al. Midlife and late-life blood pressure and dementia in Japanese elderly: The Hisayama Study. Hypertension 2011;58(1):22–8.
Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011(77):461–8.
Hebert LE, Beckett LA, Scherr PA, Evans DA. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord 2001;15(4):169–73.
State-by-state prevalence of Alzheimer’s disease: These state by state prevalence numbers are based on an unpublished analysis of incidence data from the Chicago Health and Aging Project (CHAP), projected to each state’s population, with adjustments for state-specific age, gender, years of education, race and mortality provided to the Alzheimer’s Association in 2013 by a team led by Liesi Hebert, Sc.D., from Rush University Institute on Healthy Aging.
Vincent GK, Velkof VA. The Next Four Decades: The Older Population in the United States: 2010 to 2050. Washington, D.C.: U.S. Census Bureau; 2010.
Unpublished tabulations based on data from the National 20% Sample Medicare Fee-for-Service Beneficiaries for 2009. li Prepared under contract by Julie Bynum, M.D., M.P.H., Dartmouth Institute for Health Policy and Clinical Care, Dartmouth Medical School, November 2011.
U.S. Burden of Disease Collaborators. The state of U.S. health, 1990–2010: Burden of diseases, injuries, and risk factors. JAMA 2013;310(6):591–608.
Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM. Monetary costs of dementia in the United States. N Engl J Med 2013;368:1326–34.